GINX - ETF AI Analysis
Top Page
SGI Enhanced Global Income ETF (GINX)
Rating:62Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Defensive Top Holdings
Several major holdings in areas like health care and consumer staples have delivered strong results, helping support the fund’s returns.
Broad Sector Diversification
The portfolio is spread across many sectors, which helps reduce the impact if any single industry runs into trouble.
Negative Factors
High Expense Ratio
The fund’s relatively high management fee can eat into returns compared with lower-cost income ETFs.
Heavy U.S. Concentration
Most of the assets are invested in U.S. securities, offering limited diversification across other global markets.
Notable Underperforming Holding
One of the larger financial holdings has shown weak performance year-to-date, which can drag on the fund’s overall results.
GINX vs. SPDR S&P 500 ETF (SPY)
AUM87.89M
RegionGlobal
Expense Ratio1.02%
Beta0.71
IssuerSummit Global Investments
Inception DateFeb 29, 2024
Dividend Yield5.1%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume14,521
30 Day Avg. Volume17,904
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GINX Summary
The SGI Enhanced Global Income ETF (GINX) is a global income-focused fund that does not track a specific index, but instead picks a mix of companies across many sectors and countries, with most holdings in the U.S. It aims to provide steady income from a wide range of businesses, including well-known names like TSMC, Merck, Colgate-Palmolive, JPMorgan Chase, Lockheed Martin, and PepsiCo. Someone might invest in GINX to get diversified global income and exposure to many industries in a single fund. A key risk is that its value and income can go up and down with global markets.
How much will it cost me?The SGI Enhanced Global Income ETF (GINX) has an expense ratio of 0.99%, which means you’ll pay $9.90 per year for every $1,000 invested. This is higher than average because it is actively managed, aiming to maximize global income opportunities through a dynamic and diversified strategy.
What would affect this ETF?The SGI Enhanced Global Income ETF (GINX) could benefit from global economic growth, particularly in sectors like financials and technology, which are heavily weighted in its portfolio. However, rising interest rates or regulatory changes in key industries like healthcare and energy could negatively impact its income-generating capabilities. Additionally, geopolitical tensions or economic slowdowns in regions where GINX has significant exposure may pose risks to its performance.
GINX Top 10 Holdings
GINX leans heavily on global financials, with JPMorgan and Spain’s BBVA acting as big steering wheels—though both have been lagging lately and can tug on returns when sentiment toward banks cools. On the brighter side, Taiwan’s TSMC has been a key engine, riding long-term enthusiasm for chips and AI despite some recent choppiness. Defensive names like Colgate-Palmolive, PepsiCo, and Merck provide a steadier ballast, helping smooth the ride. Overall, the fund blends income-focused financials with resilient consumer and health care giants across multiple regions.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| TSMC | 3.53% | $3.12M | $1.47T | 86.82% | 81 Outperform | |
| ― | 3.18% | $2.81M | ― | ― | ― | |
| ― | 3.08% | $2.72M | ― | ― | ― | |
| ― | 2.90% | $2.56M | ― | ― | ― | |
| Colgate-Palmolive | 2.42% | $2.14M | $68.25B | -6.32% | 63 Neutral | |
| JPMorgan Chase | 2.21% | $1.95M | $788.61B | 16.43% | 72 Outperform | |
| Banco Bilbao | 2.04% | $1.80M | $120.90B | 51.41% | 76 Outperform | |
| Merck & Company | 1.96% | $1.73M | $286.01B | 25.32% | 80 Outperform | |
| PepsiCo | 1.94% | $1.71M | $206.20B | 3.02% | 78 Outperform | |
| Magna International | 1.92% | $1.70M | $14.95B | 47.22% | 77 Outperform |
GINX Technical Analysis
Neutral
―
Price Trends
33.33
Negative
31.87
Positive
29.84
Positive
Market Momentum
-0.40
Positive
38.45
Neutral
26.90
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GINX, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 33.15, equal to the 50-day MA of 33.33, and equal to the 200-day MA of 29.84, indicating a neutral trend. The MACD of -0.40 indicates Positive momentum. The RSI at 38.45 is Neutral, neither overbought nor oversold. The STOCH value of 26.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GINX.
GINX Peer Comparison
Comparison Results
Performance Comparison
GINX
SGI Enhanced Global Income ETF
32.22
6.11
23.40%
ICAP
InfraCap Equity Income Fund ETF
―
―
―
PRAY
FIS Biblically Responsible Risk Managed ETF
―
―
―
SAGP
Strategas Global Policy Opportunities ETF
―
―
―
GOP
Unusual Whales Subversive Republican Trading ETF
―
―
―
CAMX
Cambiar Aggressive Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents